Fatty acids as potential adjunctive colorectal chemotherapeutic agents

Cancer Biology and Therapy

Volumn 11, Issue 8, 2011, Pages 724-731

  Fauser, Jane K ^a,b   Prisciandaro, Luca D ^a   Cummins, Adrian G ^b   Howarth, Gordon S ^a,c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

^c Youth and Women's Health Service   (Australia)

Author keywords

Apoptosis; Chain length fatty acids; Chemotherapy; Colorectal cancer; Fatty acids

Indexed keywords

BUTYRIC ACID; CASPASE 3; CASPASE 9; CYTOCHROME C; FATTY ACID; GLUTATHIONE; HEXANOIC ACID; HISTONE H3; HISTONE H4; LONG CHAIN FATTY ACID; MEDIUM CHAIN FATTY ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SHORT CHAIN FATTY ACID; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VALERIC ACID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL CYCLE; COLORECTAL CANCER; EPIGENETICS; IN VITRO STUDY; OXIDATIVE STRESS; REVIEW; UTERINE CERVIX CANCER;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; FATTY ACIDS; HUMANS;

EID: 79954569825     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.11.8.15281     Document Type: Review

References (97)

1. Spychalski M, Dziki L, Dziki A. Chemoprevention of colorectal cancer-a new target needed? Colorectal Dis 2007; 9:397-401. (Pubitemid 46773627)
2. Pohl A, Zhang W, Ning Y, Manegold PC, Lurje G, Lenz HJ. Targeting metastatic colorectal cancer in 2008: a long way from 5-FU. Oncology (Williston Park) 2008; 22:456-62.
3. Boursi B, Arber N. Current and future clinical strategies in colon cancer prevention and the emerging role of chemoprevention. Curr Pharm Des 2007; 13:2274-82. (Pubitemid 47317035)
4. Rupnarain C, Dlamini Z, Naicker S, Bhoola K. Colon cancer: genomics and apoptotic events. Biol Chem 2004; 385:449-64. (Pubitemid 38967772)
5. Benito M, Diaz-Rubio E. Molecular biology in colorectal cancer. Clin Transl Oncol 2006; 8:391-8.
6. Schier S, Wright NA. Stem cell relationships and the origin of gastrointestinal cancer. Oncology 2005; 69:9-13. (Pubitemid 41433535)
7. Yang L' Pei Z. Bacteria' inflammation and colon cancer. World J Gastroenterol 2006; 12:6741-6.
8. Davidson NO. Genetic testing in colorectal cancer: who' when' how and why. Keio J Med 2007; 56:14-20. (Pubitemid 46588468)
9. Terhaar Sive Droste JS' Tuynman JB' Van Dullemen HM' Mulder CJ. Chemoprevention for colon cancer: new opportunities' fact or fiction? Scand J Gastroenterol Suppl 2006; 243:158-64. (Pubitemid 43941080)
10. Wolpin BM' Meyerhardt JA' Mamon HJ' Mayer RJ. Adjuvant treatment of colorectal cancer. CA Cancer J Clin 2007; 57:168-85. (Pubitemid 46798625)
11. Berg DT. Capecitabine: a new adjuvant option for colorectal cancer. Clin J Oncol Nurs 2006; 10:479-86.
12. Astorg P. Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence. Cancer Causes Control 2004; 15:367-86. (Pubitemid 38988026)
13. Chen SL' Bilchik AJ. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg 2006; 244:602-10.
14. Carrato A. Adjuvant treatment of colorectal cancer. Gastrointest Cancer Res 2008; 2:42-6.
15. Stordal B' Pavlakis N' Davey R. Oxaliplatin for the treatment of cisplatin-resistant cancer: a systematic review. Cancer Treat Rev 2007; 33:347-57. (Pubitemid 46760527)
16. Albini A' Pennesi G' Donatelli F' Cammarota R' De Flora S' Noonan DM. Cardiotoxicity of anticancer drugs: The need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst 2009; 102:14-25.
17. Keefe DM' Brealey J' Goland GJ' Cummins AG. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 2000; 47:632-7.
18. Gibson RJ' Bowen JM' Keefe DM. Technological advances in mucositis research: new insights and new issues. Cancer Treat Rev 2008; 34:476-82.
19. Bowen JM' Gibson RJ' Keefe DM' Cummins AG. Cytotoxic chemotherapy upregulates pro-apoptotic Bax and Bak in the small intestine of rats and humans. Pathology 2005; 37:56-62. (Pubitemid 40314450)
20. van Engeland M' Nieland LJ' Ramaekers FC' Schutte B' Reutelingsperger CP. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998; 31:1-9. (Pubitemid 28050057)
21. Pajak B. Antiapoptotic proteins as targets for bioactive compounds. Pol J Vet Sci 2007; 10:127-30. (Pubitemid 46986849)
22. Jin Z' El-Deiry WS. Overview of cell death signaling pathways. Cancer Biol Ther 2005; 4:139-63. (Pubitemid 41351311)
23. Millan A' Huerta S. Apoptosis-inducing factor and colon cancer. J Surg Res 2009; 15:163-70.
24. d'Entremont TS' Sun W. Recent advances in colorectal cancer therapy. Cancer Biol Ther 2003; 2:6-13.
25. Iqbal S' Lenz HJ. Integration of novel agents in the treatment of colorectal cancer. Cancer Chemother Pharmacol 2004; 54:32-9.
26. Bergsland E' Dickler MN. Maximizing the potential of bevacizumab in cancer treatment. Oncologist 2004; 9:36-42. (Pubitemid 38747846)
27. Cross D' Burmester JK. Gene therapy for cancer treatment: past' present and future. Clin Med Res 2006; 4:218-27. (Pubitemid 44496015)
28. Lenz HJ. Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events. Oncology 2006; 20:5-13.
29. Adhikari D' Feroz F' Liefshitz A' Barakat RR' Bertino JR' Banerjee D. Pretreatment of endometrial carcinoma cell lines with butyrate results in upregulation of Bax and correlates with potentiation of radiation induced cell kill. In Vivo 2000; 14:603-9. (Pubitemid 34097520)
30. Maheo K' Vibet S' Steghens JP' Dartigeas C' Lehman M' Bougnoux P' et al. Differential sensitization of cancer cells to doxorubicin by DHA: a role for lipoperoxidation. Free Radic Biol Med 2005; 39:742-51. (Pubitemid 41139889)
31. Entin-Meer M' Rephaeli A' Yang X' Nudelman A' VandenBerg SR' Haas-Kogan DA. Butyric acid prodrugs are histone deacetylase inhibitors that show antineoplastic activity and radiosensitizing capacity in the treatment of malignant gliomas. Mol Cancer Ther 2005; 4:1952-61. (Pubitemid 43056978)
32. Dupertuis YM' Meguid MM' Pichard C. Colon cancer therapy: new perspectives of nutritional manipulations using polyunsaturated fatty acids. Curr Opin Clin Nutr Metab Care 2007; 10:427-32. (Pubitemid 46934111)
33. Coseri S. Natural products and their analogues as efficient anticancer drugs. Mini Rev Med Chem 2009; 9:560-71.
34. Lima TM' Kanunfre CC' Pompeia C' Verlengia R' Curi R. Ranking the toxicity of fatty acids on Jurkat and Raji cells by flow cytometric analysis. Toxicol In Vitro 2002; 16:741-7. (Pubitemid 35356282)
35. Matthews GM' Howarth GS' Butler RN. Short-chain fatty acid modulation of apoptosis in the kato iii human gastric carcinoma cell line. Cancer Biol Ther 2007; 6:1051-7. (Pubitemid 351574956)
36. Young GP' Hu Y' Le Leu RK' Nyskohus L. Dietary fibre and colorectal cancer: a model for environment-gene interactions. Mol Nutr Food Res 2005; 49:571-84. (Pubitemid 40853703)
37. Beermann C' Jelinek J' Reinecker T' Hauenschild A' Boehm G' Klor HU. Short term effects of dietary medium-chain fatty acids and n-3 long-chain polyunsaturated fatty acids on the fat metabolism of healthy volunteers. Lipids Health Dis 2003; 2:10.
38. Bocca C' Bozzo F' Gabriel L' Miglietta A. Conjugated linoleic acid inhibits Caco-2 cell growth via ERKMAPK signaling pathway. J Nutr Biochem 2007; 18:332-40. (Pubitemid 46590715)
39. Hinnebusch BF' Meng S' Wu JT' Archer SY' Hodin RA. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr 2002; 132:1012-7. (Pubitemid 34493567)
40. Kobayashi M' Tsubono Y' Otani T' Hanaoka T' Sobue T' Tsugane S. Fish' long-chain n-3 polyunsaturated fatty acids and risk of colorectal cancer in middle-aged Japanese: the JPHC study. Nutr Cancer 2004; 49:32-40. (Pubitemid 39299124)
41. Hall MN' Chavarro JE' Lee IM' Willett WC' Ma J. A 22-year prospective study of fish' n-3 fatty acid intake and colorectal cancer risk in men. Cancer Epidemiol Biomarkers Prev 2008; 17:1136-4.
42. Cai J' Kirlin WG' Chen Y' Yan X' Jones DP' Sartorelli AC. Overexpression of heat shock factor 1 inhibits butyrate-induced differentiation in colon cancer cells. Cell Stress Chaperones 2006; 11:199-207. (Pubitemid 44343756)
43. Matthews GM' Howarth GS' Butler RN. Nutrient and antioxidant modulation of apoptosis in gastric and colon cancer cells. Cancer Biol Ther 2006; 5:569-72. (Pubitemid 44024707)
44. Natoni F' Diolordi L' Santoni C' Gilardini Montani MS. Sodium butyrate sensitises human pancreatic cancer cells to both the intrinsic and the extrinsic apoptotic pathways. Biochim Biophys Acta 2005; 1745:318-29. (Pubitemid 41330786)
45. Choi YH. Apoptosis of U937 human leukemic cells by sodium butyrate is associated with inhibition of telomerase activity. Int J Oncol 2006; 29:1207-13.
46. Kim EH' Kim HS' Kim SU' Noh EJ' Lee JS' Choi KS. Sodium butyrate sensitizes human glioma cells to TRAIL-mediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP. Oncogene 2005; 24:6877-89. (Pubitemid 41509411)
47. Lee JC' Maa MC' Yu HS' Wang JH' Yen CK' Wang ST' et al. Butyrate regulates the expression of c-Src and focal adhesion kinase and inhibits cell invasion of human colon cancer cells. Mol Carcinog 2005; 43:207-14.
48. Chen J' Ghazawi FM' Bakkar W' Li Q. Valproic acid and butyrate induce apoptosis in human cancer cells through inhibition of gene expression of Akt/protein kinase B. Mol Cancer 2006; 5:71.
49. Xi L' Chen G' Zhou J' Xu G' Wang S' Wu P' et al. Inhibition of telomerase enhances apoptosis induced by sodium butyrate via mitochondrial pathway. Apoptosis 2006; 11:789-98. (Pubitemid 43876848)
50. Jeng JH' Kuo MY' Lee PH' Wang YJ' Lee MY' Lee JJ' et al. Toxic and metabolic effect of sodium butyrate on SAS tongue cancer cells: role of cell cycle deregulation and redox changes. Toxicology 2006; 223:235-47. (Pubitemid 43833261)
51. Jung JW' Cho SD' Ahn NS' Yang SR' Park JS' Jo EH' et al. Ras/MAP kinase pathways are involved in Ras specific apoptosis induced by sodium butyrate. Cancer Lett 2005; 225:199-206.
52. Comalada M' Bailon E' de Haro O' Lara-Villoslada F' Xaus J' Zarzuelo A' et al. The effects of short-chain fatty acids on colon epithelial proliferation and survival depend on the cellular phenotype. J Cancer Res Clin Oncol 2006; 132:487-97. (Pubitemid 43938332)
53. Emenaker NJ' Calaf GM' Cox D' Basson MD' Qureshi N. Short-chain fatty acids inhibit invasive human colon cancer by modulating uPA' TIMP-1' TIMP-2' mutant p53' Bcl-2' Bax' p21 and PCNA protein expression in an in vitro cell culture model. J Nutr 2001; 131:3041-6.
54. Lazarova DL' Bordonaro M' Carbone R' Sartorelli AC. Linear relationship between Wnt activity levels and apoptosis in colorectal carcinoma cells exposed to butyrate. Int J Cancer 2004; 110:523-31. (Pubitemid 38658017)
55. Hofmanova J' Vaculova A' Koubkova Z' Hyzd'alova M' Kozubik A. Human fetal colon cells and colon cancer cells respond differently to butyrate and PUFAs. Mol Nutr Food Res 2009; 53:102-13.
56. Jones J' Bentas W' Blaheta RA' Makarevic J' Hudak L' Wedel S' et al. Modulation of adhesion and growth of colon and pancreatic cancer cells by the histone deacetylase inhibitor valproic acid. Int J Mol Med 2008; 22:293-9.
57. Wilson AJ' Byun DS' Popova N' Murray LB' L'Italien K' Sowa Y' et al. Histone deacetylase3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J Biol Chem 2006; 281:13548-58. (Pubitemid 43855268)
58. Archer SY' Johnson J' Kim HJ' Ma Q' Mou H' Daesety V' et al. The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells. Am J Physiol Gastrointest Liver Physiol 2005; 289:696-703.
59. Gryfe R' Swallow C' Bapat B' Redston M' Gallinger S' Couture J. Molecular biology of colorectal cancer. Curr Probl Cancer 1997; 21:233-300.
60. Weekes J' Lam AK' Sebesan S' Ho YH. Irinotecan therapy and molecular targets in colorectal cancer: a systemic review. World J Gastroenterol 2009; 15:3597-602.
61. Litvak DA' Evers BM' Hwang KO' Hellmich MR' Ko TC' Townsend CM Jr. Butyrate-induced differentiation of Caco-2 cells is associated with apoptosis and early induction of p21Waf1/Cip1 and p27Kip1. Surgery 1998; 124:161-9.
62. Pajak B' Gajkowska B' Orzechowski A. Sodium butyrate sensitizes human colon adenocarcinoma COLO 205 cells to both intrinsic and TNFalpha-dependent extrinsic apoptosis. Apoptosis 2009; 14:203-17.
63. Hyzd'alova M' Hofmanova J' Pachernik J' Vaculova A' Kozubik A. The interaction of butyrate with TNFalpha during differentiation and apoptosis of colon epithelial cells: role of NFkappaB activation. Cytokine 2008; 44:33-43.
64. Ruemmele FM' Schwartz S' Seidman EG' Dionne S' Levy E' Lentze MJ. Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway. Gut 2003; 52:94-100. (Pubitemid 36020773)
65. Roy MJ' Dionne S' Marx G' Qureshi I' Sarma D' Levy E' et al. In vitro studies on the inhibition of colon cancer by butyrate and carnitine. Nutrition 2009; 11:1193-201.
66. Bonnotte B' Favre N' Reveneau S' Micheau O' Droin N' Garrido C' et al. Cancer cell sensitization to fasmediated apoptosis by sodium butyrate. Cell Death Differ 1998; 5:480-7. (Pubitemid 28356566)
67. Golubovskaya VM' Cance WG. Focal Adhesion Kinase and p53 Signaling in Cancer Cells. Int Rev Cytol 2007; 263:103-53. (Pubitemid 47296394)
68. McWilliams RR' Erlichman C. Novel therapeutics in colorectal cancer. Dis Colon Rectum 2005; 48:1632-50. (Pubitemid 41032091)
69. Buda A' Qualtrough D' Jepson MA' Martines D' Paraskeva C' Pignatelli M. Butyrate downregulates alpha2beta1 integrin: a possible role in the induction of apoptosis in colorectal cancer cell lines. Gut 2003; 52:729-34. (Pubitemid 36528877)
70. Levy P' Robin H' Bertrand F' Kornprobst M' Capeau J. Butyrate-treated colonic Caco-2 cells exhibit defective integrin-mediated signaling together with increased apoptosis and differentiation. J Cell Physiol 2003; 197:336-47. (Pubitemid 37487032)
71. Wang TG' Gotoh Y' Jennings MH' Rhoads CA' Aw TY. Lipid hydroperoxide-induced apoptosis in human colonic CaCo-2 cells is associated with an early loss of cellular redox balance. Faseb J 2000; 14:1567-76. (Pubitemid 30636561)
72. Aw TY. Molecular and cellular responses to oxidative stress and changes in oxidation-reduction imbalance in the intestine. Am J Clin Nutr 1999; 70:557-65. (Pubitemid 29463451)
73. Domokos M' Jakus J' Szeker K' Csizinszky R' Csiko G' Neogrady Z' et al. Butyrate-induced cell death and differentiation are associated with distinct patterns of ROS in HT29-derived human colon cancer cells. Dig Dis Sci 2009; 55:920-30.
74. Miyamoto S' Suzuki R' Yasui Y' Kohno H' Sugie S' Murakami A' et al. Lack of enhancing effect of lauric acid on the development of aberrant crypt foci in male ICR mice treated with azoxymethane and dextran sodium sulfate. J Toxicol Pathol 2007; 20:93-100.
75. Beauchamp E' Rioux V' Legrand P. [New regulatory and signal functions for myristic acid]. Med Sci (Paris) 2009; 25:57-63.
76. Endo Y' Hanada K' Miyake M' Ogawara K' Higaki K' Kimura T. Mechanisms of cytoprotective effect of amino acids on local toxicity caused by sodium laurate' a drug absorption enhancer' in intestinal epithelium. J Pharm Sci 2002; 91:730-43. (Pubitemid 34639636)
77. Lindmark T' Kimura Y' Artursson P. Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. J Pharmacol Exp Ther 1998; 284:362-9. (Pubitemid 28109567)
78. Coyne CB' Ribeiro CM' Boucher RC' Johnson LG. Acute mechanism of medium chain fatty acid-induced enhancement of airway epithelial permeability. J Pharmacol Exp Ther 2003; 305:440-50. (Pubitemid 36459156)
79. Bartolotta S' Garcia CC' Candurra NA' Damote EB. Effect of fatty acids on arenavirus replication: inhibition of virus production by lauric acid. Arch Virol 2001; 146:777-90. (Pubitemid 32437312)
80. Hornung B' Amtmann E' Sauer G. Lauric acid inhibits the maturation of vesicular stomatitis virus. J Gen Virol 1994; 75:353-61. (Pubitemid 24050393)
81. Petschow BW' Batema RP' Ford LL. Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids. Antimicrob Agents Chemother 1996; 40:302-6. (Pubitemid 26049339)
82. Galdiero F' Carratelli CR' Nuzzo I' Bentivoglio C' De Martino L' Gorga F' et al. Beneficial effects of myristic' stearic or oleic acid as part of liposomes on experimental infection and antitumor effect in a murine model. Life Sci 1994; 55:499-509. (Pubitemid 24230336)
83. Veeresh Babu SV' Veeresh B' Patil AA' Warke YB. Lauric acid and myristic acid prevent testosterone induced prostatic hyperplasia in rats. Eur J Pharmacol 626:262-5.
84. Engelbrecht AM' Toit-Kohn JL' Ellis B' Thomas M' Nell T' Smith R. Differential induction of apoptosis and inhibition of the PI3-kinase pathway by saturated' monounsaturated and polyunsaturated fatty acids in a colon cancer cell model. Apoptosis 2008; 13:1368-77.
85. Kato T' Kolenic N' Pardini RS. Docosahexaenoic acid (DHA)' a primary tumor suppressive omega-3 fatty acid' inhibits growth of colorectal cancer independent of p53 mutational status. Nutr Cancer 2007; 58:178-87. (Pubitemid 47328769)
86. Bozzo F' Bocca C' Colombatto S' Miglietta A. Antiproliferative effect of conjugated linoleic acid in Caco-2 cells: involvement of PPARgamma and APC/ beta-catenin pathways. Chem Biol Interact 2007; 169:110-21. (Pubitemid 47125873)
87. Kemp MQ' Jeffy BD' Romagnolo DF. Conjugated linoleic acid inhibits cell proliferation through a p53-dependent mechanism: effects on the expression of G1-restriction points in breast and colon cancer cells. J Nutr 2003; 133:3670-7. (Pubitemid 37409505)
88. Narayanan BA' Narayanan NK' Reddy BS. Docosahexaenoic acid regulated genes and transcription factors inducing apoptosis in human colon cancer cells. Int J Oncol 2001; 19:1255-62.
89. Schonberg SA' Lundemo AG' Fladvad T' Holmgren K' Bremseth H' Nilsen A' et al. Closely related colon cancer cell lines display different sensitivity to polyunsaturated fatty acids' accumulate different lipid classes and downregulate sterol regulatory element-binding protein 1. Febs J 2006; 273:2749-56.
90. Das UN. Essential fatty acids' lipid peroxidation and apoptosis. Prostaglandins Leukot Essent Fatty Acids 1999; 61:157-63. (Pubitemid 29520805)
91. Rivabene R' Napolitano M' Cantafora A' Bravo E. Redox-dependent modulation of lipid synthesis induced by oleic acid in the human intestinal epithelial cell line Caco-2. Exp Biol Med (Maywood) 2001; 226:191-8. (Pubitemid 32506381)
92. Nano JL' Nobili C' Girard-Pipau F' Rampal P. Effects of fatty acids on the growth of Caco-2 cells. Prostaglandins Leukot Essent Fatty Acids 2003; 69:207-15. (Pubitemid 37463800)
93. Toit-Kohn JL' Louw L' Engelbrecht AM. Docosahexaenoic acid induces apoptosis in colorectal carcinoma cells by modulating the PI3 kinase and p38MAPK pathways. J Nutr Biochem 2009; 20:106-14.
94. Kim EJ' Holthuizen PE' Park HS' Ha YL' Jung KC' Park JH. Trans-10' cis-12-conjugated linoleic acid inhibits Caco-2 colon cancer cell growth. Am J Physiol Gastrointest Liver Physiol 2002; 283:357-67.
95. Lampen A' Leifheit M' Voss J' Nau H. Molecular and cellular effects of cis-9' trans-11-conjugated linoleic acid in enterocytes: effects on proliferation' differentiation and gene expression. Biochim Biophys Acta 2005; 1735:30-40. (Pubitemid 40814511)
96. Hossain Z' Hosokawa M' Takahashi K. Growth inhibition and induction of apoptosis of colon cancer cell lines by applying marine phospholipid. Nutr Cancer 2009; 61:123-30.
97. Bharali DJ' Khalil M' Gurbuz M' Simone TM' Mousa SA. Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers. Int J Nanomedicine 2009; 4:1-7.